The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic Dermatitis

Exclusion Criteria

• •Females who are pregnant, lactating, or planning/intending to be pregnant in the next 6 months.
• •Participants who are participating in another trial.
• •Participants with active chronic or acute infection requiring systemic treatment.
• •Participants who are diagnosed with active endoparasite infection or are suspected of being at high risk of infection.
• •Participants with human immunodeficiency virus (HIV), hepatitis B or C, malignancy, or other concomitant illnesses.
• •Participants on antidepressants/anti-anxiety within 6 months of enrolment or those who are planning to receive antidepressants/anti-anxiety. In addition, those who will use antidepressants/anti-anxiety medications throughout the study will be excluded from the analysis.
• •The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.